Prescription Required
To treat benign prostatic hypertrophy, alfuzosin is a nonselective alpha-1 adrenergic antagonist applied topically. Alfuzosin is linked to a low incidence of momentary rises in serum aminotransferase levels and a rare occurrence of acute liver injury that is clinically noticeable.
If your liver impairment is mild to severe, you shouldn't use this medicine. It is unknown if the medicine is safe for use in individuals with mild hepatic impairment. If you believe you may have a liver impairment or have any questions about this, please see your physician.
A dose modification might be required. If you have kidney impairment or have any concerns about this, please see your physician.
While using this medicine, it is advised that you avoid or consume alcohol in moderation as it may worsen your dizziness.
It medicine may make you feel lightheaded. If you're not paying attention, don't use machinery or drive.
Women, especially those who are pregnant, should not use this medicine; it is exclusively meant for use in males.
It medicine is not recommended for use by women; it is exclusively meant for use by men.
It works by blocking receptors on the bladder, urethra, and prostate gland (urinary pipe). When ALFUZOSIN relaxes the muscles of the bladder and prostate, the urethra doesn't narrow as much.
Within the male reproductive system, the prostate is a tiny, muscular gland that surrounds the urethra. The non-cancerous expansion of the prostate gland brought on by cell proliferation is known as benign prostatic hyperplasia. Most cases of benign prostatic hypertrophy/hyperplasia affect older males.
Master in Pharmacy
Content Updated on
Thursday, 12 September, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA